By transfecting the full-length cDNA for human von Willebrand factor (vWf) into a line of Chinese hamster ovary cells with a defect in carbohydrate metabolism, we have prepared recombinant vWf specifically lacking O-linked carbohydrates. We have compared this under-glycosylated protein to fully glycosylated recombinant vWf with respect to several structural and binding properties. vWf deficient in O-linked glycans was synthesized, assembled into multimers, and secreted in an apparently normal manner and was not prone to degradation in the extracellular milieu. It did not differ from fully glycosylated vWf in ability to bind to heparin or to collagen type I but did interact less well with glycoprotein 1b on formalin-fixed platelets. This decreased interaction was evidenced in both a lessened overall binding to platelets and in diminished capacity to promote platelet agglutination, in the presence of ristocetin. In contrast, no difference was seen in platelet binding in the presence of botrocetin. These data indicate a possible role for O-linked carbohydrates in the vWf-glycoprotein 1b interaction promoted by ristocetin and suggest that abnormalities in carbohydrate modification might contribute to the altered ristocetin-dependent reactivity between vWf and platelets described for some variant forms of von Willebrand disease.
J A Carew, S M Quinn, J H Stoddart, D C Lynch
Title and authors | Publication | Year |
---|---|---|
O-glycan determinants regulate VWF trafficking to Weibel-Palade bodies
Karampini E, Doherty D, Bürgisser PE, Garre M, Schoen I, Elliott S, Bierings R, O\u2019Donnell JS |
Blood Advances | 2024 |
The Biological Significance of von Willebrand Factor O-Linked Glycosylation
S Ward, JM O'Sullivan, JS O'Donnell |
Seminars in thrombosis and hemostasis | 2021 |
Synthetic glycopolymers and natural fucoidans cause human platelet aggregation via PEAR1 and GPIbα
C Kardeby, K Fälker, EJ Haining, M Criel, M Lindkvist, R Barroso, P Påhlsson, LU Ljungberg, M Tengdelius, GE Rainger, S Watson, JA Eble, MF Hoylaerts, J Emsley, P Konradsson, SP Watson, Y Sun, M Grenegård |
Blood Advances | 2019 |
Biologic roles of the ABH and Lewis histo‐blood group antigens part II: thrombosis, cardiovascular disease and metabolism
SR Stowell, CP Stowell |
Vox Sanguinis | 2019 |
Patterns and levels of platelet glycosylation in patients with coronary heart disease and type 2 diabetes mellitus
L Li, C Qu, X Wu, J Dai, Y Lu, Y Gong, R You, Y Liu |
Journal of Thrombosis and Thrombolysis | 2017 |
Mutant botrocetin-2 inhibits von Willebrand factor-induced platelet agglutination
T Matsui, A Hori, J Hamako, F Matsushita, Y Ozeki, Y Sakurai, M Hayakawa, M Matsumoto, Y Fujimura |
Journal of Thrombosis and Haemostasis | 2017 |
Quantitative Influence of ABO Blood Groups on Factor VIII and Its Ratio to von Willebrand Factor, Novel Observations from an ARIC Study of 11,673 Subjects
J Song, F Chen, M Campos, D Bolgiano, K Houck, LE Chambless, KK Wu, AR Folsom, D Couper, E Boerwinkle, J Dong, T Miyata |
PloS one | 2015 |
von Willebrand factor, Jedi knight of the bloodstream
TA Springer |
Blood | 2014 |
Platelet biogenesis and functions require correct protein O-glycosylation
Y Wang, SM Jobe, X Ding, H Choo, DR Archer, R Mi, T Ju, RD Cummings |
Proceedings of the National Academy of Sciences | 2012 |
Structure and function of von Willebrand factor :
MI Hassan, A Saxena, F Ahmad |
Blood Coagulation & Fibrinolysis | 2012 |
O-linked glycosylation of von Willebrand factor modulates the interaction with platelet receptor glycoprotein Ib under static and shear stress conditions
AA Nowak, K Canis, A Riddell, MA Laffan, TA McKinnon |
Blood | 2012 |
In Vivo Analysis of the Role of O-Glycosylations of Von Willebrand Factor
I Badirou, M Kurdi, P Legendre, J Rayes, M Bryckaert, C Casari, PJ Lenting, OD Christophe, CV Denis, T Miyata |
PloS one | 2012 |
The Tn Antigen-Structural Simplicity and Biological Complexity
T Ju, VI Otto, RD Cummings |
Angewandte Chemie (International ed. in English) | 2011 |
Das Tn-Antigen - strukturell einfach und biologisch komplex
T Ju, VI Otto, RD Cummings |
Angewandte Chemie | 2011 |
The plasma von Willebrand factorO-glycome comprises a surprising variety of structures including ABH antigens and disialosyl motifs
K Canis, TA Mckinnon, A Nowak, M Panico, HR Morris, M Laffan, A Dell |
Journal of Thrombosis and Haemostasis | 2010 |
A comparison of nano-electrospray gas-phase electrophoretic mobility macromolecular analysis and matrix-assisted laser desorption/ionization linear time-of-flight mass spectrometry for the characterization of the recombinant coagulation glycoprotein von Willebrand factor
J Kemptner, M Marchetti-Deschmann, R Müller, A Ivens, P Turecek, HP Schwarz, G Allmaier |
Rapid Communications in Mass Spectrometry | 2010 |
Factor VIII and von Willebrand factor - too sweet for their own good
PJ Lenting, JN Pegon, OD Christophe, CV Denis |
Haemophilia | 2010 |
Recent Advances in Thrombosis and Hemostasis 2008
K Tanaka, EW Davie, Y Ikeda, S Iwanaga, H Saito, K Sueishi |
2008 | |
Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival
SL Haberichter, M Balistreri, P Christopherson, P Morateck, S Gavazova, DB Bellissimo, MJ Manco-Johnson, JC Gill, RR Montgomery |
Blood | 2006 |
ABO blood group determines plasma von Willebrand factor levels: a biologic function after all?
PV Jenkins, JS O?Donnell |
Transfusion | 2006 |
O-Linked glycosylation and functional incompatibility of porcine von Willebrand factor for human platelet GPIb receptors
JS Esch, SC Robson, WT Knoefel, SB Hosch, X Rogiers |
Xenotransplantation | 2005 |
Impact ofO-linked glycosylation of the VWF-A1-domain flanking regions on platelet interaction
JS Esch, SC Robson, WT Knoefel, CF Eisenberger, M Peiper, X Rogiers |
British Journal of Haematology | 2005 |
Impact of O -linked glycosylation of the VWF-A1-domain flanking regions on platelet interaction
JS Esch, SC Robson, WT Knoefel, CF Eisenberger, M Peiper, X Rogiers |
British Journal of Haematology | 2005 |
Re-establishment of VWF-dependent Weibel-Palade bodies in VWD endothelial cells
SL Haberichter, EP Merricks, SA Fahs, PA Christopherson, TC Nichols, RR Montgomery |
Blood | 2005 |
Critical independent regions in the VWF propeptide and mature VWF that enable normal VWF storage
SL Haberichter, P Jacobi, RR Montgomery |
Blood | 2003 |
Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands
LG Ellies, D Ditto, GG Levy, M Wahrenbrock, D Ginsburg, A Varki, DT Le, JD Marth |
Proceedings of the National Academy of Sciences | 2002 |
Role of A and B blood group antigens in the expression of adhesive activity of von Willebrand factor
R Sarode, J Goldstein, II Sussman, RL Nagel, HM Tsai |
British Journal of Haematology | 2000 |
Von Willebrand factor storage and multimerization: 2 independent intracellular processes
SL Haberichter, SA Fahs, RR Montgomery |
Blood | 2000 |
Recombinant von Willebrand factor: potential therapeutic use
B E Fischer |
Journal of Thrombosis and Thrombolysis | 1999 |
von Willebrand disease: Pathogenesis, classification, and management
EW Murray, D Lillicrap |
Transfusion Medicine Reviews | 1996 |
EFFECT OF MULTIMERIZATION OF HUMAN AND RECOMBINANT VON WILLEBRAND FACTOR ON PLATELET AGGREGATION, BINDING TO COLLAGEN AND BINDING OF COAGULATION FACTOR VIII
BE Fischer, G Kramer, A Mitterer, L Grillberger, M Reiter, W Mundt, F Dorner, J Eibl |
Thrombosis Research | 1996 |
Promotion of binding of von Willebrand factor to platelet glycoprotein Ib by dimers of ristocetin
MF Hoylaerts, K Nuyts, K Peerlinck, H Deckmyn, J Vermylen |
Biochemical Journal | 1995 |
Purification and characterization of human platelet von Willebrand factor
SB Williams, LP McKeown, H Krutzsch, K Hansmann, HR Gralnick |
British Journal of Haematology | 1994 |
The interaction of the von Willebrand factor-A1 domain with platelet glycoprotein Ib/IX. The role of glycosylation and disulfide bonding in a monomeric recombinant A1 domain protein
MA Cruz, RI Handin, RJ Wise |
The Journal of biological chemistry | 1993 |